Historic 'living drug' gets go-ahead

Historic 'living drug' gets go-ahead
 

The US has approved the first treatment to redesign a patient's own immune system so it attacks cancer.
The regulator - the US Food and Drug Administration - said its decision was a "historic" moment and medicine was now "entering a new frontier".
The company Novartis is charging $475,000 (£367,000) for the therapy, which leaves 83% of people free of a type of blood cancer.
Doctors in the UK said the announcement was an exciting step forward.
The "living drug" is tailor-made to each patient, unlike conventional therapies such as surgery or chemotherapy.
It is... read more

 
30 August 2017 in Health, Views: 47
Source: BBC
Share:
  •  




    News Widget for Webmasters


    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
        1 2 3 4 5
    6 7 8 9 10 11 12
    13 14 15 16 17 18 19
    20 21 22 23 24 25 26
    27 28 29 30